Ann Silk

Dr. Silk is a medical oncologist specializing in cutaneous oncology at Dana-Farber Cancer Institute. She conducts clinical trials using microbial-based cancer therapies, cytokines, and immune checkpoint inhibitors, and is particularly interested in the intratumoral delivery of therapeutics and the treatment of brain metastases. Dr. Silk has been a member of SITC since 2013 and was a member of the Planning Committee for the inaugural ASCO-SITC Clinical Immuno-Oncology Symposium. She currently serves on the Communications Committee, the Certificate Program, and is the co-chair of the Cancer Immunotherapy Guideline development committee for cutaneous squamous cell carcinoma. She is an Associate Editor of the Oncolytic and Local Immunotherapy section of JITC and a co-leader of the Cytokine Working Group. Dr. Silk received her medical degree and master’s degree in Clinical Research from the University of Pittsburgh in 2008 and completed a fellowship in hematology and oncology at the University of Michigan in 2014. She joined the faculty at Dana-Farber Cancer Institute in 2019, where she is the Co-Director of the Merkel Cell Carcinoma Center of Excellence.

Companies

• Assistant Professor Harvard Medical School (2021)
• Medical Oncologist Dana-Farber Cancer Institute (2019)
• Assistant Professor Rutgers Cancer Institute of New Jersey (2014 — 2018)
• Hematology and Oncology Fellow University of Michigan (2011 — 2014)
• Resident in Internal Medicine UPMC (2008 — 2011)

Education

• Doctor of Medicine - MD University of Pittsburgh School of Medicine (2003 — 2008)
• Swarthmore College